00:05 , Dec 12, 2018 |  BC Extra  |  Company News

Management tracks: Merck creates new commercial roles to follow Schechter's exit

Merck & Co. Inc. (NYSE:MRK) said President of Global Human Health Adam Schechter will step down at the end of the year. The company will restructure his former position into two new roles effective Jan....
05:02 , Jan 19, 2018 |  BC Week In Review  |  Company News

Context acquires onapristone from Arno

Cancer company Context Therapeutics (Philadelphia, Pa.) acquired worldwide rights to Apristor onapristone XR from Arno Therapeutics Inc. (Flemington, N.J.) for an undisclosed one-time payment. In December, Arno announced that it would dissolve and turn over...
20:32 , Feb 16, 2017 |  BC Week In Review  |  Company News

NexImmune deal

An investor group acquired immuno-oncology company NexImmune for an undisclosed amount. The group includes Sol Barer, former Celgene Corp. (NASDAQ:CELG, Summit, N.J.) chairman and CEO and current chairman of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel...
18:08 , Feb 14, 2017 |  BC Extra  |  Financial News

Barer among investors acquiring NexImmune

An investor group including former CEOs of Celgene Corp. (NASDAQ:CELG) and Medtronic plc (NYSE:MDT) has acquired immuno-oncology company NexImmune Inc. (Gaithersburg, Md.) for an undisclosed amount. The group includes Sol Barer, the former Celgene chairman...
07:00 , Jul 11, 2016 |  BioCentury  |  Finance

Advising Israel

BC Staff  A new Israeli VC fund is leveraging a broad base of biopharma advisers to give its portfolio companies an advantage in development, partnering and commercialization activities. Israel Biotech Fund is raising its first...
07:00 , Jun 9, 2016 |  BC Innovations  |  Strategy

Sanofi's post-reconstruction era

Lauren Martz, Senior Writer  Five years after taking the helm as Sanofi 's president of global R&D, Elias Zerhouni is rounding out his strategy to revamp the division and rebuild the pipeline with the appointment...
07:00 , Jun 8, 2015 |  BioCentury  |  Emerging Company Profile

Financing innovation in China

Yabao Pharmaceutical Group Co. Ltd. is seeking VCs to join it in financing a new spinout that has aspirations to participate in global development of novel drugs. Newco Suzhou Yabao Pharmaceutical R&D Co. Ltd. is...
08:00 , Feb 5, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Viral protein 1 (VP1)

Infectious disease INDICATION: Enterovirus In vitro studies suggest the antiviral compound pleconaril could help treat enterovirus 68 (EV68) infection. In a cell-based assay, pleconaril inhibited the activity of the Fermon CA62-1 strain of EV68 at...
08:00 , Feb 2, 2015 |  BioCentury  |  Politics, Policy & Law

Dr. Califf goes to Washington

FDA has had three deputy commissioners during the Obama administration ; each was expected to play a major role in shaping the agency, and none of them lived up to expectations. Last week's announcement that...
08:00 , Jan 29, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Phosphodiesterase-4 (PDE-4); fragile X mental retardation 1 (FMR1)

Neurology INDICATION: Fragile X syndrome Mouse and fly studies suggest that PDE-4 inhibitors could help treat cognitive impairment in patients with fragile X syndrome. In a fly model of fragile X syndrome, cAMP levels in...